Status:
UNKNOWN
Comparing the Spanish Version of CANreduce With or Without Psychological Support and Treatment as Usual, Reducing Cannabis Use.
Lead Sponsor:
Parc de Salut Mar
Collaborating Sponsors:
Research Institute for Public Health and Addiction, Switzerland
Conditions:
Cannabis Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cannabis is the most widely used psychoactive substance around the world after alcohol and tobacco. Although approximately one in ten users develop serious problems of dependency, only a small number ...
Eligibility Criteria
Inclusion
- Cannabis use of at least once a week 30 days prior to study entry
- At least 18 years old
- At least weekly internet access and a valid email address
Exclusion
- Participant reports current pharmacological psychiatric disease or history of psychosis, schizophrenia, bipolar type I disorder or significant current suicidal or homicidal thoughts
- Use of other pharmacological and psychosocial treatments for cannabis use disorders
- Inability to read or write in Spanish
Key Trial Info
Start Date :
November 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04517474
Start Date
November 10 2020
End Date
December 1 2022
Last Update
November 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juan-Ignacio Mestre-Pinto
Barcelona, Catalonia, Spain, 08003